{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:46:47Z","timestamp":1787014007884,"version":"build-2736575974"},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Congenital Anomalies"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Given the paucity of safety data on fluoroquinolone antibiotics in pregnancy, a prospective observational cohort study was conducted in pregnant women who sought help and advice on drug use at two teratology information institutes in Japan. The primary endpoint of the study was the incidence of major congenital anomalies. The study population included pregnant women exposed to (i) fluoroquinolones (fluoroquinolone group), (ii) \u03b2\u2010lactams (infectious control group), or (iii) other agents considered to be nonteratogenic in humans (nonteratogenic control group) during the first trimester. The frequency of major congenital anomalies was compared across groups using a logistic regression model that adjusted for maternal age, smoking status, drinking status, facility consulted, and time of consultation. The fluoroquinolone group consisted of 411 women who had 383 children born alive. The infectious control and nonteratogenic control groups consisted of 1416 and 1482 women who had 1322 and 1401 children born alive, respectively. The incidence of major congenital anomalies was 1.5%, 2.0%, and 1.6% in the fluoroquinolone group, infectious control, and nonteratogenic control groups, respectively. Logistic regression showed that fluoroquinolone exposure is not a significant risk factor for major congenital anomalies. In conclusion, first\u2010trimester exposure to fluoroquinolone antibiotics was not associated with increased maternal or fetal risks.<\/jats:p>","DOI":"10.1111\/cga.12577","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T20:38:59Z","timestamp":1719520739000},"page":"199-206","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pregnancy outcomes after first\u2010trimester exposure to fluoroquinolones:\n                    <scp>Findings<\/scp>\n                    based on an integrated database from two\n                    <scp>Japanese<\/scp>\n                    institutions"],"prefix":"10.1111","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-9275","authenticated-orcid":false,"given":"Mikako","family":"Goto","sequence":"first","affiliation":[{"name":"Pregnancy and Drug Information Center The Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1073-2996","authenticated-orcid":false,"given":"Tatsuhiko","family":"Anzai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, M&amp;D Data Science Center Tokyo Medical and Dental University  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuko","family":"Yamane","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Toranomon Hospital  Minato\u2010ku Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-6221","authenticated-orcid":false,"given":"Naho","family":"Yakuwa","sequence":"additional","affiliation":[{"name":"Pregnancy and Drug Information Center The Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-7772","authenticated-orcid":false,"given":"Kunihiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, M&amp;D Data Science Center Tokyo Medical and Dental University  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Murashima","sequence":"additional","affiliation":[{"name":"Pregnancy and Drug Information Center The Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2018.01.003"},{"issue":"8","key":"e_1_2_7_3_1","first-page":"1244","article-title":"Reproductive toxicity of ofloxacin","volume":"36","author":"Takayama S","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02413-14"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0301-2115(95)02524-3"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.35772\/ghm.2020.01120"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14709"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318295fe12"},{"issue":"11","key":"e_1_2_7_9_1","first-page":"1976","article-title":"Pregnancy outcomes of exposure to methimazole (POEM) study","volume":"70","author":"Arata N","year":"2012","journal-title":"Nihon Rinsho"},{"key":"e_1_2_7_10_1","unstructured":"eurocat.EUROCAT Guide 1.4 and Reference Documents (Last update version 15\/11\/2019) [Internet].https:\/\/eu-rd-platform.jrc.ec.europa.eu\/sites\/default\/files\/JRC-EUROCAT-Full-Guide-1.4-version-15-Nov-2019.pdf"},{"key":"e_1_2_7_11_1","volume-title":"R: A Language and Environment for Statistical Computing [Internet]","author":"R Core Team"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1336"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.31662\/jmaj.2022-0087"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.06.017"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2018.05.009"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2016.11.019"}],"container-title":["Congenital Anomalies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cga.12577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T04:55:12Z","timestamp":1725252912000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cga.12577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1111\/cga.12577"],"URL":"https:\/\/doi.org\/10.1111\/cga.12577","archive":["Portico"],"relation":{},"ISSN":["0914-3505","1741-4520"],"issn-type":[{"value":"0914-3505","type":"print"},{"value":"1741-4520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"2024-02-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}